Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Evolution of New Traits in Microbes01:24

Evolution of New Traits in Microbes

Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
Criticisms of the Evolutionary Perspective01:23

Criticisms of the Evolutionary Perspective

In a study where individuals posing as strangers offered compliments and proposed casual sex to students, the responses differed significantly based on gender. Not a single woman accepted the proposal, while 70% of the men agreed. This outcome provides a useful scenario to explore through the lens of evolutionary psychology and social learning theory, highlighting the diverse perspectives on human sexual behaviors.
Evolutionary psychology provides one explanation for these findings, suggesting...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the ALS Multistep Model.

Brain sciences·2026
Same author

Memories of Mark. Personal reflections by those in IFCN who worked with Mark Hallett.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

The Neonatal Microbiome: Implications for Amyotrophic Lateral Sclerosis and Other Neurodegenerations.

Brain sciences·2025
Same author

Amyotrophic lateral sclerosis represents corticomotoneuronal system failure.

Muscle & nerve·2024
Same author

Nanoplastics and Neurodegeneration in ALS.

Brain sciences·2024
Same author

The glymphatic system and Amyotrophic lateral sclerosis.

Progress in neurobiology·2024

Related Experiment Video

Updated: Jun 21, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Amyotrophic lateral sclerosis-Evolutionary and other perspectives.

Andrew Eisen1

  • 1Division of Neurology, Department of Medicine, 2862 Highbury Street, Vancouver, British Columbia V6R 3T6, Canada. eisen@interchange.ubc.ca

Muscle & Nerve
|July 18, 2009
PubMed
Summary

Amyotrophic lateral sclerosis (ALS) may stem from neocortical circuitry dysfunction, potentially beginning in adolescence or earlier. The unique neocortical evolution in humans may explain why animal models fail to replicate ALS.

More Related Videos

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 21, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
07:43

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

Published on: January 7, 2019

Area of Science:

  • Neuroscience
  • Evolutionary Biology
  • Neurology

Background:

  • Amyotrophic lateral sclerosis (ALS) presents puzzling aspects, including its clinical manifestations and onset.
  • Neurodegenerative diseases like ALS are often linked to dysfunctional neocortical circuitry.
  • The evolutionary trajectory of the human neocortex is a key consideration.

Purpose of the Study:

  • To explore particular and puzzling aspects of amyotrophic lateral sclerosis (ALS).
  • To emphasize the role of neocortical evolution in ALS.
  • To discuss the timing of ALS onset and its relationship to neocortical changes.

Main Methods:

  • Review and discussion of existing literature on ALS.
  • Analysis of anatomical and evolutionary aspects of the neocortex, motor cortex, and corpus callosum.
  • Exploration of the nature of the clinical deficit in ALS.

Main Results:

  • ALS may originate from dysfunctional neocortical circuitry.
  • The disease may initiate years before clinical symptoms, possibly in adolescence or earlier, marked by neocortical alterations.
  • The unique neocortical evolution in humans might explain the limitations of current animal models for ALS.

Conclusions:

  • Dysfunctional neocortical circuitry is a potential cause of ALS.
  • ALS onset may precede clinical diagnosis by many years, linked to early neocortical changes.
  • Human-specific neocortical evolution presents challenges for developing accurate animal models of ALS.